Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

FOSCARNET vs VALGANCICLOVIR: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

FOSCARNET vs VALGANCICLOVIR: Safety Overview

Metric FOSCARNET VALGANCICLOVIR
Total FAERS Reports 2,057 7,913
Deaths Reported 605 1,274
Death Rate 29.4% 16.1%
Hospitalizations 608 3,092
Average Patient Age 41.8 yrs 48.8 yrs
% Female Patients 40.6% 41.2%
FDA Approval Date Apr 21, 2021 Apr 11, 2023
Manufacturer Hikma Pharmaceuticals USA Inc. NorthStar RxLLC
Route INTRAVENOUS ORAL
Marketing Status Prescription Prescription